XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | 9.39%29.89B | 50.62%35.96B | 66.50%41.8B | -46.75%59.57B | -686.16%-16.74B | 13.66%27.32B | -13.98%23.87B | -56.13%25.11B | -7.02%111.87B | 1,586.98%2.86B |
Other non cash items | 751.70%3.27B | -88.33%720M | -371.53%-6.24B | 117.28%23.98B | 82.49%19.64B | -15.17%-501M | 154.56%6.17B | 22.66%-1.32B | 3,017.80%11.04B | 756.77%10.76B |
Change In working capital | -62.64%-20.29B | 91.05%-3.11B | 46.90%2.37B | 27.80%-32.71B | -82.80%12.91B | 71.61%-12.47B | 35.73%-34.76B | 107.23%1.61B | 48.10%-45.3B | 178.76%75.06B |
-Change in receivables | -75.18%-22.99B | 150.28%25.83B | -40.47%18.7B | -1,608.96%-51.38B | -125.90%-18.3B | 52.94%-13.13B | -10.49%-51.36B | 341.39%31.41B | 110.05%3.41B | 164.58%70.66B |
-Change in inventory | 131.35%1.93B | -186.18%-15.6B | 29.23%-15.73B | 168.02%22.86B | 31.96%33.13B | -101.48%-6.14B | 253.60%18.1B | 49.36%-22.22B | 55.75%-33.61B | 436.99%25.11B |
-Change in other current assets | -483.78%-1.08B | -514.50%-1.09B | -387.30%-1.23B | 75.20%-1.08B | -6.97%-906M | 94.27%-185M | 300.00%262M | -64.71%-252M | 25.72%-4.36B | -25.85%-847M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -22.50%30.96B | 169.40%59.18B | 28.74%57.08B | 27.87%185.68B | -36.18%79.44B | 4,464.80%39.94B | 844.39%21.97B | 94.31%44.34B | 5.01%145.21B | 62.06%124.47B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Net PPE purchase and sale | -74.18%-51.45B | -17.64%-40.47B | -38.26%-35.95B | -33.62%-131.73B | -31.51%-41.79B | -30.28%-29.54B | -59.25%-34.4B | -15.37%-26B | -10.88%-98.59B | -19.92%-31.78B |
Net business purchase and sale | ---225M | ---- | --0 | ---6.46B | --0 | --0 | --0 | ---6.46B | --0 | --0 |
Net investment purchase and sale | 915.37%43.46B | 247.57%24.7B | -2.41%2.18B | 492.52%19.64B | 2,792.79%6.02B | 151.91%4.28B | 412.03%7.11B | 11,090.00%2.24B | -91.12%3.32B | 229.19%208M |
Net other investing changes | 105.20%188M | 30.64%1.37B | -73.27%-2.74B | 67.08%-2.45B | 235.25%1.69B | -225.86%-3.62B | 189.14%1.05B | 59.63%-1.58B | -876.54%-7.45B | -404.44%-1.25B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 72.20%-8.03B | 45.15%-14.4B | -14.79%-36.5B | -17.79%-121B | -3.85%-34.08B | -30.75%-28.87B | -22.67%-26.24B | -20.32%-31.8B | -79.69%-102.72B | -20.86%-32.82B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | -39.06%17.74B | -4,103.04%-50.12B | 90.67%-974M | -278.31%-53.35B | 7.92%-73.28B | -27.49%29.11B | -54.90%1.25B | -146.26%-10.44B | 78.86%-14.1B | -196.02%-79.58B |
Cash dividends paid | -0.10%-14.36B | 7.63%-557M | -0.30%-13.85B | -5.89%-28.83B | 2.82%-69M | -0.01%-14.35B | 1.95%-603M | -13.25%-13.81B | -35.98%-27.23B | -18.33%-71M |
Net other financing activities | 11.11%-8M | 288.89%17M | 81.03%-48M | 40,359.15%28.58B | 99,600.00%28.86B | 40.00%-9M | -800.00%-9M | -873.08%-253M | -2,266.67%-71M | -2,800.00%-29M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -242.05%-15.81B | -1,029.46%-55.94B | 28.26%-20.75B | -22.64%-70.37B | 42.34%-47.62B | -49.59%11.13B | -74.96%-4.95B | -584.24%-28.92B | 43.48%-57.38B | -174.97%-82.59B |
Net cash flow | ||||||||||
Beginning cash position | 3.81%220.7B | 14.51%247.97B | 5.31%235.89B | -2.76%224B | 6.89%229.39B | -6.08%212.59B | -12.53%216.54B | -2.76%224B | -2.54%230.36B | 6.16%214.61B |
Current changes in cash | -67.90%7.13B | -20.91%-11.16B | 98.95%-172M | 61.80%-5.69B | -125.04%-2.27B | 2,477.82%22.2B | 66.04%-9.23B | -794.19%-16.38B | 27.01%-14.89B | -53.79%9.07B |
Effect of exchange rate changes | 314.20%11.55B | -405.34%-16.11B | 37.19%12.25B | 106.11%17.58B | 2,647.65%8.77B | 57.20%-5.39B | -11.46%5.28B | -39.86%8.93B | -40.77%8.53B | -96.28%319M |
End cash Position | 4.35%239.38B | 3.81%220.7B | 14.51%247.97B | 5.31%235.89B | 5.31%235.89B | 6.89%229.39B | -6.08%212.59B | -12.53%216.54B | -2.76%224B | -2.76%224B |
Free cash flow | -312.97%-20.86B | 241.94%18.57B | 1.25%17.55B | 19.89%51.55B | -58.30%37.5B | 144.57%9.79B | 47.11%-13.08B | 8,089.86%17.34B | -6.71%43B | 83.56%89.92B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |